Skip to main content

Loss of Human Epidermal Receptor 2 Expression in Formalin-Fixed Paraffin-Embedded Breast Cancer Samples and the Rescuing Effect of Enhanced Antigen Retrieval and Signal Amplification.

Ma X, Zhou L, Wu Q, Jia L, Long M, Kang Q, Huang X, Liu Y, Hu T, Diao X

Publication: Life (Basel) (2023) • Vol 14PMID: 38255647View on PubMed

Purpose

This paper investigated the effects of the duration of formalin-fixed paraffin-embedded (FFPE) block storage on HER2 antigenicity by comparing HER2 immunohistochemical (IHC) staining in fresh sections of archival breast cancer blocks with the case-matched original HER2 IHC slide or pathology report. Additionally, the authors investigate whether increasing the antigen retrieval incubation time or performing tyramide signal amplification could rescue the storage-associated loss in HER2 antigenicity.

Conclusion

HER-2 staining in the original IHC slide or pathology report was classified as 0, 1+, 2+, and 3+ in 6, 69, 15 and 6 specimens, respectively. As none of the HER2+ specimens had HER2 amplification (FISH analysis), 84 specimens were characterized as HER2-low (69 specimens were HER2 1+ and 15 specimens were HER2 2+ and FISH negative). While only 7.7% of FFPE block specimens (2 of 26) that were stored for 1 year showed decreased HER2 staining relative to the initial section, FFPE blocks that were stored for longer durations displayed a significantly higher percentage of specimens with reduced staining (2-4 y, 57.1%, P=0.000129; 5-10 y, 52.9%, P=0.001948; 11-15 y, 65%, P=0.001948;  and >15 y, 40% P=0.0318). Importantly, reductions in staining did not progress with block storage duration, as FFPE blocks stored for 2-4, 5-10, 11-15, and >15 y did not differ significantly from one another, indicating that HER2 antigenicity stabilizes after the initial loss. The percentage of specimens that were initially HER2-low  (HER2 1+ or HER2 2+ and FISH negative) but were HER2 negative after FFPE block storage was also higher for specimens stored 2-4, 5-10, 11-15 and >15 years than those stored for <1 year (58%, 47%, 63% and 100%, respectively versus 9%; P<0.05 all). This was mainly driven by the percentage of specimens that changed from HER2 1+ to HER2 zero being higher for specimens stored 2-4, 5-10, 11-15 and >15 years than those stored for <1 year (65%, 55%, 73% and 100% versus 10%). While there was no effect of increasing the duration of the antigen retrieval step or including a tyramide signal amplification step on HER2 staining in a control specimen, HER2 staining was restored to the original levels in 10 of 21 specimens by elongating the antigen retrieval step (from 36 to 92 min) and in 9 of 21 specimens by including tyramide signal amplification. Importantly, all cases rescued by tyramide signal amplification were also rescued by lengthening the antigen retrieval step.

Studies (1)

Purpose

This study investigated the effects of the duration of formalin-fixed paraffin-embedded (FFPE) block storage on HER2 antigenicity by comparing HER2 immunohistochemical (IHC) staining in fresh sections of archival breast cancer blocks with the case-matched original HER2 IHC slide or pathology report. Additionally, the authors investigate whether increasing the antigen retrieval incubation time or performing tyramide signal amplification could rescue the storage-associated loss in HER2 antigenicity. Archival FFPE breast cancer blocks stored for < 1 year (26 specimens), 2-4 years (28 specimens), 5-10 years (17 specimens), 11-15 years (20 specimens) and >15 years (5 specimens) were freshly sectioned. A section (4 μm thick) was immunohistochemically stained using the same HER2 antibody used during initial analysis (VENTANA 4B5 antibody if after 2008 and HER2 antibody of clone CB11 if before 2008). HER2 status was defined as HER2-low if IHC staining was 1+ or 2+ and FISH negative based on the American Society of Clinical Oncology/College of American Pathologists guidelines. HER2 staining scores were compared with those for the case-matched slide generated for initial analysis and stained prior to storage (reanalyzed or obtained from pathology report); any loss of antigenicity was characterized.  For specimens that showed reduced antigenicity compared to the original slide, IHC staining was repeated in separate experiments that included an elongated antigen retrieval step (92 min versus 36 min at 95°C) or the Optiview Amplification Kit (tyramide signal amplification) in conjunction with the Optiview DAB IHC detection Kit.

Summary of Findings

HER-2 staining in the original IHC slide or pathology report was classified as 0, 1+, 2+, and 3+ in 6, 69, 15 and 6 specimens, respectively. As none of the HER2+ specimens had HER2 amplification (FISH analysis), 84 specimens were characterized as HER2-low (69 specimens were HER2 1+ and 15 specimens were HER2 2+ and FISH negative). While only 7.7% of FFPE block specimens (2 of 26) that were stored for 1 year showed decreased HER2 staining relative to the initial section, FFPE blocks that were stored for longer durations displayed a significantly higher percentage of specimens with reduced staining (2-4 y, 57.1%, P=0.000129; 5-10 y, 52.9%, P=0.001948; 11-15 y, 65%, P=0.001948;  and >15 y, 40% P=0.0318). Importantly, reductions in staining did not progress with block storage duration, as FFPE blocks stored for 2-4, 5-10, 11-15, and >15 y did not differ significantly from one another, indicating that HER2 antigenicity stabilizes after the initial loss. The percentage of specimens that were initially HER2-low  (HER2 1+ or HER2 2+ and FISH negative) but were HER2 negative after FFPE block storage was also higher for specimens stored 2-4, 5-10, 11-15 and >15 years than those stored for <1 year (58%, 47%, 63% and 100%, respectively versus 9%; P<0.05 all). This was mainly driven by the percentage of specimens that changed from HER2 1+ to HER2 zero being higher for specimens stored 2-4, 5-10, 11-15 and >15 years than those stored for <1 year (65%, 55%, 73% and 100% versus 10%). While there was no effect of increasing the duration of the antigen retrieval step or including a tyramide signal amplification step on HER2 staining in a control specimen, HER2 staining was restored to the original levels in 10 of 21 specimens by elongating the antigen retrieval step (from 36 to 92 min) and in 9 of 21 specimens by including tyramide signal amplification. Importantly, all cases rescued by tyramide signal amplification were also rescued by lengthening the antigen retrieval step.

  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    StorageStorage duration
    11-15 years
    2-4 years
    5-10 years
    <1 year
    >15 years
    Analyte Extraction and PurificationAntigen retrieval
    36 min
    92 min
    Immunohistochemistry SpecificSignal amplification
    No tyramide signal amplification
    Tyramide signal amplification